![]() |
![]() |
| Anim Biosci > Volume 38(8); 2025 > Article |
|
AUTHORS’ CONTRIBUTION
Conceptualization: Kubota S, Paengkoum P.
Data curation: Kubota S, Wongdee T.
Formal analysis: Kubota S.
Methodology: Kubota S.
Investigation: Kubota S, Wongdee T.
Writing - original draft: Kubota S.
Writing - review & editing: Kubota S, Wongdee T, Paengkoum P.
FUNDING
This work was supported by (i) Suranaree University of Technology, (ii) Thailand Science Research and Innovation (TSRI), (iii) the National Science, Research and Innovation Fund (NSRF), NRIIS number 195593, and (iv) the National Research Council of Thailand (NRCT).
DATA AVAILABILITY
Upon reasonable request, the datasets of this study can be available from the corresponding author.
ETHICS APPROVAL
The study was approved by the Animal Care and Use Committee of the Suranaree University of Technology (SUT, Nakhon Ratchasima, Thailand) (SUT 4/2558). The research was conducted following regulations on animal experiments and the Guidelines for the Use of Animals in Research, as recommended by the National Research Council of Thailand (U1-08780-2563).
| Traits | Abbreviation of traits | Mean | Minimum | Maximum | Standard deviation | p-value for Shapiro–Wilk test2) |
|---|---|---|---|---|---|---|
| Litter size at first parity | LS1 | 1.12 | 1 | 2 | 0.34 | 0.001* |
| Litter size at second parity | LS2 | 1.45 | 1 | 2 | 0.50 | 0.001* |
| Litter size at third parity | LS3 | 1.77 | 1 | 2 | 0.42 | 0.001* |
| Age at first parity (days) | AP1 | 762 | 380 | 1313 | 242 | 0.612 |
| Age at second parity (days) | AP2 | 1156 | 662 | 1815 | 313 | 0.299 |
| Age at third parity (days) | AP3 | 1655 | 922 | 2451 | 356 | 0.939 |
| Interval between the first and second parities (days) | I1 | 393 | 52 | 860 | 219 | 0.031* |
| Interval between the second and third parities (days) | I2 | 499 | 114 | 1142 | 276 | 0.058 |
| Interval between the first and third parities (days) | I3 | 893 | 455 | 1498 | 309 | 0.108 |
| Items | Mean |
|---|---|
| Raw base (bp) | 1,337,801,472 |
| Clean base (bp) | 1,337,336,167 |
| Q20 (%)2) | 95.27 |
| GC content (%) | 40.61 |
| Mapped reads | 9,263,800 |
| Mapping rate (%) | 99.72 |
| Depth (×) | 7.14 |
| Coverage at least 4× (%) | 3.38 |
| Total number of SNPs | 304,852 |
| K2) | Mean LnP(K)3) | Standard deviation of LnP(K) | Delta K | Cross-validation error |
|---|---|---|---|---|
| 1 | −605,510.00 | 33.32 | Not applicable | 0.55 |
| 2 | −585,023.30 | 145.09 | 52.19 | 0.57 |
| 3 | −572,110.48 | 176.21 | 45.41 | 0.64 |
| 4 | −567,200.35 | 265.42 | 4.20 | 0.75 |
| 5 | −563,405.98 | 685.19 | Not applicable | 0.83 |
| SNP name | Chromosome | SNP position | Reference allele/alternate allele | p-value | Gene at SNP | Genes near SNP1) |
|---|---|---|---|---|---|---|
| S4_115015047 | 4 | 115015047 | G/T | 3.73E–09 | - | IKZF1, FIGNL1, DDC |
| S11_23594751 | 11 | 23594751 | A/G | 1.65E–08 | - | - |
| S24_58531767 | 24 | 58531767 | G/C | 1.61E–07 | - | RAX, CPLX4, LMAN1, CCBE1 |
| S29_41094205 | 29 | 41094205 | G/C | 8.29E–06 | ASRGL1 | LOC102180194, LOC102180465, LOC106503745, AHNAK |
| S29_41094263 | 29 | 41094263 | C/T | 8.25E–06 | ASRGL1 | LOC102180194, LOC102180465, LOC106503745, AHNAK |
| S29_41094340 | 29 | 41094340 | C/T | 8.25E–06 | ASRGL1 | LOC102180194, LOC102180465, LOC106503745, AHNAK |
SNP, single nucleotide polymorphism; IKZF1, IKAROS family zinc finger 1; FIGNL1, fidgetin-like 1; DDC, dopa decarboxylase; RAX, retina and anterior neural fold homeobox; CPLX4, complexin 4; LMAN1, lectin, mannose binding 1; CCBE1, collagen and calcium binding EGF domains 1; ASRGL1, asparaginase and isoaspartyl peptidase 1; LOC102180194, secretoglobin family 1D member; LOC102180465, mammaglobin-A; LOC106503745, uncharacterized LOC106503745; AHNAK, AHNAK nucleoprotein.

![]() |
![]() |